Seres Therapeutics
MCRB
MCRB
133 hedge funds and large institutions have $554M invested in Seres Therapeutics in 2021 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 48 increasing their positions, 33 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
9% less funds holding
Funds holding: 146 → 133 (-13)
31% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 42
71% less capital invested
Capital invested by funds: $1.93B → $554M (-$1.37B)
Holders
133
Holding in Top 10
1
Calls
$4.7M
Puts
$2.77M
Top Buyers
| 1 | +$45.5M | |
| 2 | +$33.6M | |
| 3 | +$5.85M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.84M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$5.63M |
Top Sellers
| 1 | -$232M | |
| 2 | -$30.7M | |
| 3 | -$30.7M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$20.8M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$17.1M |